Pfizer to Present Phase 1 Data on MesoC2 ADC at ASCO 2025

Nona Biosciences announced that its collaborator, Pfizer, will present the Phase 1 clinical study design of MesoC2 (HBM9033/PF-08052666), a first-in-c...
Home/KnloSights/Clinical Trial Updates/Pfizer to Present Phase 1 Data on MesoC2 ADC at ASCO 2025